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Madin–Darby Canine KidneyThe Adenomatous Polyposis Coli (APC) tumor suppressor has been previously implicated in the control of apical–
basal polarity; yet, the consequence of APC loss-of-function in epithelial polarization andmorphogenesis has not
been characterized. To test the hypothesis that APC is required for the establishment of normal epithelial polarity
and morphogenesis programs, we generated APC-knockdown epithelial cell lines. APC depletion resulted in loss
of polarity andmulti-layering onpermeable supports, and enlarged,ﬁlled spheroidswith disruptedpolarity in 3D
culture. Importantly, these effects of APC knockdown were independent of Wnt/β-catenin signaling, but were
rescuedwith either full-length or a carboxy (c)-terminal segment of APC.Moreover, we identiﬁed a gene expres-
sion signature associated with APC knockdown that points to several candidates known to regulate cell–cell and
cell–matrix communication. Analysis of epithelial tissues frommice and humans carrying heterozygous APCmu-
tations further supports the importance of APC as a regulator of epithelial behavior and tissue architecture. These
data also suggest that the initiation of epithelial-derived tumors as a result of APCmutation or gene silencingmay
be driven by loss of polarity and dysmorphogenesis.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Epithelial morphogenesis is a tightly coordinated process that re-
quires extrinsic and intrinsic cues to couple cell–cell and cell–matrix in-
teractions, polarity, proliferation, cell death, and differentiation. In
contrast to traditional two-dimensional (2D) culture on glass or plastic,
the organotypic 3D culture of epithelial cells in extracellular matrix
(ECM), such as the reconstituted basement membrane Matrigel or col-
lagen, is a powerful in vitro model that recapitulates many of the fea-
tures of tissue polarity and architecture (reviewed in [83]). Common
features of these organoid or spheroid models (conventionally referredh thrombospondin type 1,motif
it of type IV collagen; CXCR7, C–
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elialmembrane protein 2; FAK,
sis; GEF, Guanine-exchange fac-
Loss of heterozygosity; MDCK,
ctivated kinase
ol of Medicine — South Bend,
Notre Dame Ave., Harper Hall
; fax: +1 574 631 8932.
.to as “acini” for mammary cells and “cysts” for kidney cells) are that
after a couple of cell divisions of plated single cells, they polarize to
form a basal surface that contacts the ECM, a lateral surface between
cells, and an apical surface which faces the lumen. Apoptosis will
occur in those cells that do not contact the ECM, and cells that do not
yet have an apical surface will generally form a lumen at the point of
contact with other cells (reviewed in [9]). Recent insights into the mo-
lecular mechanisms that guide polarization and lumen formation, for
example, have supported the importance of junction and polarity com-
plexes, laminins, integrins, phosphoinositides and Rho GTPase family
members in these processes [35,50,81,82,85]. Importantly, these polar-
ity and morphogenesis programs are often disrupted or hijacked in
pathological conditions such as chronic wounds, kidney ﬁbrosis and
cancer; therefore, a more complete understanding of the pathways
and critical players involved has signiﬁcant clinical relevance.
The Adenomatous Polyposis Coli (APC – by convention, the mouse
gene is Apc, the human gene is APC, and the protein from either species
is APC) tumor suppressor is a large, multifunctional protein that is fre-
quently mutated or down-regulated in epithelial-derived cancers, in-
cluding colorectal, breast and renal cancers, among many others
(reviewed in [56,57]). A current view of APC function is as a scaffold
that facilitates the assembly or stability of multi-protein complexes,
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characterized activity of APC controls β-catenin levels and signaling
via the canonical Wnt signaling pathway, APC associates with many
other protein partners. At its carboxy-terminus, which is invariably
lost if APC is mutated, APC binds directly and indirectly to the microtu-
bule (MT) and actin cytoskeleton [45,46,48,54,65,70,71] aswell as to the
Dlg and Scrib basolateral domain identity proteins [41,72]. APC also in-
teracts with the Rac and Cdc42 guanine-exchange factors (GEFs) Asef-1
andAsef-2, the Rac andCdc42 effector IQGAP1, the plus-endMTbinding
protein EB1, the kinesin family members KAP3, KIF3 and KIF17, and the
formin mDia ([55] for review). It is likely that through these protein–
protein interactions and others, APC affects a broad set of activities in
normal epithelial cells in addition to controlling the levels of β-catenin
and Wnt signaling.
Previous work from our laboratory and others has established a link
of APC to polarity and tissue architecture. Endogenous and exogenous
APC is concentrated in puncta at the ends of cell protrusions in motile
cells, such as astrocytes, radial glia or subconﬂuent epithelial cells,
where it associates with the microtubules and is required for front–
rear polarity downstream of the Cdc42 Rho GTPase [5,17,18,36,49,62,
80]. In polarized epithelia in vitro and in vivo, APC localizes to the
basal plasma membrane [42,58,65] in an actin-dependent fashion [65],
where it controls the establishment of parallel arrays of microtubule
bundles [42]. However, there are also reports of APC localization to
the apical membrane of polarized epithelial cell types, including in
the differentiated mammary epithelium [58,63]. Our laboratory has
demonstrated that heterozygous Apc mutation abrogates mammary
lobuloalveologenesis by inhibiting proliferation during pregnancy, in-
ducing apoptosis during lactation and severely altering epithelial integ-
rity, including cell–cell interactions and polarity [58]. Furthermore,
knockdown of APC in MadinDarby Canine Kidney (MDCK) cells
perturbsmitotic spindle orientation [15] that can lead tomonolayer dis-
ruption, and APC expression in EpH4 mammary epithelial cells was re-
quired for normal monolayer formation [58]. APC also mediates
directionality of cell extrusion from an epithelial monolayer through
its control of microtubule dynamics [39]. However, key questions re-
garding the role of APC in epithelial morphogenesis and the mecha-
nisms by which APC mediates these behaviors remain unanswered,
and, importantly, it has not been established whether this is one of
the essential ways in which APC acts as a tumor suppressor.
In the current study, we test the hypothesis that APC function is re-
quired for normal epithelial polarity and 3D morphogenesis. By estab-
lishing in vitro models of stable APC knockdown in multiple epithelial
cell lines, we found that APC is required for monolayer formation in
2D and normal spheroid morphogenesis in 3D culture. The effects of
APC depletion were rescued with overexpression of either full-length
or a carboxy (c)-terminal fragment of APC, but not by a central region
containing the β-catenin-binding domain. These data are consistent
with the interactions between APC and cystoskeletal and/or polarity
complex proteins being required for normal polarity and morphogene-
sis programs, but the phenotypes associated with APC knockdown do
not involve activation of the Wnt signaling pathway. These data high-
light the importance of APC as a regulator of epithelial behavior and tis-
sue architecture, and suggest that tumor initiation as a result of APC
mutation or inactivation may be driven by loss of proper apical–basal
polarity and dysmorphogenesis.
2. Results
2.1. Polarity and morphogenesis are disrupted in mammary epithelial cells
with APC knockdown
We have previously shown that Apcmutation perturbed mammary
epithelial polarity in vivo [58]. Therefore, to identify themechanisms in-
volved, an in vitro model was generated in which APC was stably
knocked down in the HC11 mouse mammary epithelial cell line usinglentiviral infection of APC-speciﬁc shRNAs. Western blot analysis con-
ﬁrmed that APC expression was signiﬁcantly reduced in APC shRNA
cells compared to the vector and control scrambled shRNA cells
(Fig. 1A,B). In order to assess the impact of APC depletion on epithelial
monolayer formation, control shRNA HC11 and APC shRNA HC11 cells
were plated on Transwell ﬁlters and grown to conﬂuence. The APC
shRNA HC11 cells demonstrated a phenotype of multilayering with
mislocalization of the polarity markers, Dlg, Scrib, MUC1, and β-catenin
(Fig. 1C, Supplemental Fig. 1). Unlike control cells in which Dlg, Scrib
and β-catenin are restricted to the basolateral surface and MUC1 is api-
cally restricted, there was pronounced intracellular localization of these
markers and staining all around the membrane in APC-knockdown
cells. Because the phenotype is heterogeneous, there are confounding is-
sues in separation of the morphological defects from the mislocalization
of apical and basal markers. However, it is of note that there is no evi-
dence of β-catenin translocation to the nucleus observed in APC shRNA
cells, which is consistent with our previous ﬁndings in the mammary
glands of ApcMin/+ females [58]. Similar to other breast epithelial cell
lines, such as MCF-10A, HC11 cells will form acinar structures in 3D
Matrigel culture conditions and can differentiate a normal versus inva-
sive phenotype [78]. To test the impact of APC loss on 3Dmorphogenesis,
single cells were plated in Matrigel, and we found that the APC shRNA
HC11 cells demonstrated a marked increased acinar size (Fig. 1D,E). In
addition, the APC shRNA HC11 acini develop more invasive structures
with cell extensions protruding into the Matrigel, which is not observed
in control acini (Fig. 1D). No changes in cell proliferation or apoptosis
were observed via phospho-Histone H3 or cleaved caspase 3 staining re-
spectively (data not shown). These data suggest a role for APC in the po-
larization and morphogenesis of breast-derived epithelial cells.
2.2. APC knockdown disrupts cyst morphology and polarity in MDCK cells
We next sought to address the role for APC in establishing or main-
taining polarity, and identify the molecular mechanisms responsible, in
theMDCK cell line because it is a robust and verywell studiedmodel sys-
tem for investigating epithelial polarization and morphogenesis. MDCK
cells with stable expression of APC shRNA were generated using the
same system as the HC11 cells. Western blot analysis conﬁrmed that
APC protein levelsweremarkedly decreased in theAPC shRNA cells com-
pared to the controls (Fig. 2A,B). In addition to APC knockdown inMDCK
cells causing multi-layering on Transwells like HC11 cells (data not
shown), these cells plated in 3D Matrigel cultures exhibited very large
and highly disorganized cysts in the APC shRNA cells compared to the
control cells by phase-contrast microscopy (Fig. 2E). These qualitative
differences were conﬁrmed by morphometric analysis of the phase-
contrast images and demonstrated that the cysts were larger in the
APC shRNA cells compared to the control cells (Fig. 2F). Not only were
these phenotypes observed with multiple APC-speciﬁc shRNAs (data
not shown), but also the stable introduction of full-length APC (hAPC-
FL) was able to rescue this phenotype (Fig. 2E,F) conﬁrming that normal
MDCK 3D morphogenesis is dependent on APC. For the rescue experi-
ments, it is important to note that the construct contains the human
APC cDNA and is not targeted by the APC shRNA.
To dissect the region of APC required for the altered cyst size, we
generated cell lines stably expressing a large central segment of APC
tagged with GFP (APCmid; residues 220–2164) and the c-terminus
of APC tagged with GFP (APCc-ter; residues 2165–2843) in APC-
knockdown and control cells (Fig. 2C), and compared them to expres-
sion of the vector only and full-length APC (as a positive control for
phenotype rescue as shown in Fig. 2E,F). Expression of these fragments
was conﬁrmed throughWestern blots of APC (Fig. 2D), and immunoﬂu-
orescence staining for GFP (Supplemental Fig. 2). Notably, this central
segment is necessary and sufﬁcient for β-catenin binding and down-
regulation [47,66], and the c-terminal fragment associates with the
MT and actin cytoskeleton, and Dlg and Scrib polarity proteins [4,41,
46,48,72]. While the APCmid fragment had minimal effect on cyst size,
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Fig. 1.APC knockdowndisrupts polarization andmorphogenesis inmammary epithelial cells. A) APC protein expression inHC11 cells was analyzed byWestern blot. B)Western Blot anal-
ysis of APC expression in HC11 cells normalized to actin expression. C) Control and APC-knockdown HC11 cells were plated on Transwell permeable supports for 5 days and analyzed for
the localization of polarized protein markers, β-catenin (top row, green), Dlg (2nd row, green), Scribble (3rd row, red) and MUC1 (bottom row, red). All were co-stained with phalloidin
andHoechst (blue). Arrows showbasolateral (β-catenin, Dlg and Scrib) and apical (MUC1)distribution of themarkers in control cells andmislocalization and intracellular accumulation in
the APC-knockdown cells. Multi-layering is apparent in the APC-knockdown cells. X–Z confocal planes are shown. D) Phase-contrast images of HC11 cells grown in 3DMatrigel cultures
demonstrate larger, disorganized acini in cells with APC silencing compared to controls. Scale bars, 100 μm. E) Quantiﬁcation of the acinus size indicated that APC-knockdown HC11 cells
generated larger acini (*p b 0.05 via Fisher's exact test). Representative images are shown of experiments, which were all performed three times.
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cells compared to APC shRNA cells stably expressing the vector control
(Fig. 2E,F).
To further assess the impact of APC depletion onMDCK 3Dmorpho-
genesis and polarization, MDCK control and APC shRNA cells were
plated in Matrigel over a time course of 7 days and analyzed by immu-
noﬂuorescence and confocal microscopy for the localization of the api-
cal marker gp135 (also referred to as podocalyxin) and phalloidin to
stain F-actin. While the lumens observed at 3 days post-plating in the
MDCK control cells were quite small, gp135 was localized to apical cell
surface adjacent to these early lumens (Fig. 3A), which is consistent
with previous analysis of MDCK 3D morphogenesis in Matrigel [16,
35]. After 7 days in culture, the lumens of MDCK cell cysts were gener-
ally hollow, and most cysts exhibited only a single lumen. In striking
contrast, the APC shRNA cells formed many cysts without lumens and
gp135 was frequently localized to basal surface (Fig. 3A), an effect that
was observed as early as 3 days post-plating and very pronounced byday 7. Like the gross cyst morphological defects observed in APC-
knockdown cells (i.e. increased size and non-spherical shape), the lack
of discernible lumens and mis-localization of gp135 were abrogated
by introduction of full-length APC (Fig. 3B,C). Similar to the effect of
theAPC fragments on cyst size, the APCc-ter fragment, but not the APCmid
fragment, partially rescued the polarized expression of membrane
markers in the APC-knockdown cells (Fig. 3B,C). These data demon-
strate that the c-terminus of APC mediates epithelial polarization and
morphogenesis, and suggest that one consequence of APC mutation
and deletion of the c-terminus during tumorigenesis is loss of polarity
and tissue architecture.
2.3. The morphogenesis effects of APC knockdown are not associated with
Wnt/β-catenin pathway activation
Because activation of the Wnt/β-catenin pathway is such a well-
characterized consequence of APC mutation in tumor cells, we next
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was insufﬁcient to activate reporter activity above baseline (normalized
to the activity observed in cells transfected with a mutant FOPﬂash re-
porter) (Fig. 4A). These ﬁndings are also consistent with a lack of cyto-
solic or nuclear β-catenin accumulation observed in APC-knockdown
MDCK cells (data not shown) and failure of APC knockdown in HC11
cells (described earlier) to demonstrate TOPﬂash reporter activity
(data not shown). Furthermore, treatment with LiCl (known to activate
Wnt signaling) induced reporter activity in bothMDCK control and APC
knockdown cells (Supplemental Fig. 3A). It is possible that the β-
catenin/TCF transcriptional reporter assay and β-catenin immunoﬂuo-
rescence are not sensitive enough to detect subtle, but biologically rele-
vant, levels of Wnt pathway activation subsequent to APC knockdown.
Therefore, as a complementary approach, we generated an MDCK cell
line with inducible Wnt/β-catenin pathway activity. The T23 “tetracy-
cline-off” MDCK cells [6] were stably transfected with an expression
vector containing a HA-tagged non-phosphorylatable, non-degradable,
transcriptionally active S37Aβ-catenin mutant [26] under the control
of a tetracycline (or doxycycline, DOX)-responsive promoter. As expect-
ed, the removal of doxycycline from the culture media induced the ex-
pression of mutant β-catenin (Fig. 4B, Supplemental Fig. 3B),
increased nuclear β-catenin expression (Fig. 4C, D), and did not increase
reporter activity compared to control cells (Fig. 4A). To assess whether
overexpression of stabilized β-catenin would disrupt MDCK morpho-
genesis and polarization similar to APC knockdown, the T23-S37A β-
catenin-HA MDCK cells were plated in 3D culture using Matrigel in
the presence or absence of doxycycline for 7 days and subjected to
gp135 and phalloidin immunoﬂuorescence and confocal microscopy.
In both the presence and absence of doxycycline, we observed apical lo-
calization of gp135with the stabilizedβ-catenin (Fig. 4E) and no change
in cyst size (Fig. 4F). While 3D morphogenesis in the stabilized β-
catenin cells was not completely normal (i.e. fewer cysts had hollow lu-
mens), they did not phenocopy the APC-knockdown cells with respect
to increased size, apical marker inversion and disrupted cyst morpholo-
gy (Figs. 2, 3). Collectively, these data indicate that robust activation of
β-catenin stabilization and β-catenin/TCF-mediated transcription are
unlikely to account for cyst dysmorphogenesis and altered polarity ob-
served in APC-depleted MDCK cells.
2.4. Gene proﬁling experiments identify candidates for mediating
APC-regulated epithelial morphogenesis
Given that the effects of APC-knockdown inMDCK cells could not be
fully explained byWnt/β-catenin activation,we addressed other poten-
tial molecular mechanisms responsible by gene expression proﬁling to
identify candidate pathways or molecules dysregulated upon APC
knockdown. In addition, we sought to address whether the APC-
knockdown cells could be used as a tool to identify a gene signature as-
sociatedwith APC deﬁciency and epithelial polarity andmorphogenesis.
Gene expression microarray analysis was performed on RNA from con-
trol shRNA and APC shRNAMDCK cells grown in 3DMatrigel culture for
5 days, a time point when the polarity inversion and dysmorphogenesis
phenotypes are pronounced in APC-knockdown cells (n = 3 per cell
line). Surprisingly, comparison of APC shRNA to control shRNA MDCK
cells at this time point demonstrated that only 125 genes were signiﬁ-
cantly differentially expressed (i.e. N1.2-fold change; 75 up-regulated
and 50 down-regulated). A representative heat-map of the signatureFig. 2.MDCK 3Dmorphogenesis is perturbed by APC knockdown and restored by re-introducti
protein expression inMDCK cells was quantiﬁed and normalized to actin expression. C) Schema
(bottom) and APCmid and APCc-ter fragments. D) APC protein expression inMDCK cells with exp
c-terminus of APC (APCc-ter) was analyzed byWestern Blot and normalized to actin expression
cyst size and alteredmorphology in APC-knockdown cell compared to controls (left panels). Th
(hAPC-FL), APCmid, or APCc-ter. Scale bars, 100 μm. F) Cyst size was increased in APC-knockdown
hAPC-FL. The enhanced cyst size was signiﬁcantly abrogated by introduction of the APCc-ter co
experiments, which were all performed three times.is shown (Fig. 5A), and the differential expression of multiple genes
was validated by real-time RT-PCR (Fig. 5B). Consistent with the report-
er assays described earlier, no characterized β-catenin/TCF target genes
were contained in this APC-knockdown signature. Some of the genes in
the signature had been previously linked to APC loss-of-function, and
are generally implicated in mediating epithelial cell–cell or cell–matrix
interactions. For example, epithelial membrane protein 2 (EMP2),
which has been shown to regulate the activity and phosphorylation of
focal adhesion kinase (FAK) through interaction with β1 integrin [21,
43,44] was signiﬁcantly up-regulated in the APC shRNA MDCK cells.
This alteration in gene expression is of particular interest given our pre-
vious observations that mutation or loss of APC controls FAK activity in
breast tumor cells [56,57], and that inhibition of β1 integrin signaling,
like APC depletion, confers an inverted polarity phenotype in MDCK
cells [53,81]. The transmembrane glycoprotein MUC16 was also up-
regulated in the APC shRNA MDCK cells. MUC16 has been implicated
in early tumor development in both pancreatic and ovarian models [7,
10,25], andwe have previously shown that APC is required for the local-
ization of a related membrane-associated mucin, MUC1 [58]. Interest-
ingly, down-regulation of Lipocalin 2 (LCN2), a marker for kidney
injury [74], implicated in kidney epithelial cell morphogenesis [24]
and previously shown to be dysregulated in ApcMin/+ intestinal adeno-
mas [61], was observed in the APC shRNAMDCK cells. Other dysregulat-
ed genes including the alpha 1 subunit of type IV collagen (COL4A1, a
basement membrane component), C–X–C chemokine receptor type 7
(CXCR7), and ADAM metallopeptidase with thrombospondin type 1,
motif 6 (ADAMTS6), are implicated in controlling cell–cell or cell–ma-
trix interactions [1,8,28,37]. These data collectively support a model in
whichAPC loss-of-function in epithelial cells (throughmutation andde-
letion of its c-terminus or gene silencing) leads to loss of polarity and
tissue architecture, and subsequent tumor initiation, via altered com-
munication between neighboring cells and the substratum.
2.5. APC mutation in vivo perturbs kidney and colonic epithelial
architecture
These data demonstrating that APC is required for epithelial cell line
monolayer and 3D spheroid formation provide an in vitro correlate to
our previous observations that epithelial integrity was compromised
in germline heterozygous Apc-mutant mammary tissues [58]. To ad-
dress how generalizable this role for APC is in epithelia and whether
our in vitro models are physiologically relevant, we turned back to the
ApcMin/+ mouse model and used immunohistochemistry and immuno-
ﬂuorescence to analyze the localization of polarizedmembranemarkers
in intestinal and kidney tissues. In Apc+/+ colon tissues, the localization
of the adherens junction components β-catenin and E-cadherin was re-
stricted to the basolateral domain between adjacent differentiated epi-
thelial cells as expected (Fig. 6A, Supplemental Fig. 4A). However, in
non-adenomatous ApcMin/+ colon tissues, the localization of these
markerswas heterogeneous: it was restricted to the basolateral domain
in some cells, wasmore diffuse at themembrane in others and cytosolic
inmany (Fig. 6A, Supplemental Fig. 4A).Moreover, multi-layering of the
epithelium was observed, and only very focal nuclear β-catenin accu-
mulation, as a surrogate for Wnt signaling, was detectable in
microadenomas (Fig. 6A, Supplemental Fig. 4A). In the kidney tissues
from wild-type mice, apical localization of MUC1 is pronounced in the
distal convoluted tubules (Fig. 6B) as has been described previouslyon of APC. A) APC protein expression in MDCK cells was analyzed byWestern blot. B) APC
tic of the full-length APC protein including functional domains (top) and binding partners
ression of human full-length APC (hAPC-FL), the central fragment of APC (APCmid), and the
. E) Phase-contrast images of MDCK and APC-knockdownMDCK cysts show an increase in
e 2nd–4th columns show the phenotypewith ectopic expression of human full-length APC
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717A.C. Lesko et al. / Biochimica et Biophysica Acta 1853 (2015) 711–723[79]. In contrast, the localization of MUC1 is more diffuse and intracellu-
lar in ApcMin/+ kidney tissues as described in lactating mammary tissues
from thesemice [58]. Moreover, defects in the kidney tissue architecture
are characterized by gaps between tubules, some epithelial multi-
layering and disorganization of the tubule structure (Fig. 6B). Finally,
we examined tissue architecture in non-adenomatous regions of colon
tissue isolated from familial adenomatous polyposis (FAP) patients by
analyzing β-catenin and MUC1 localization by immunoﬂuorescence
(Fig. 6C, Supplemental Fig. 4B). While some areas retained normalhistology, β-catenin was diffusely cytosolic in some cells and localized
to the basal membrane in others and MUC1 showed intracellular accu-
mulation in many cells. We additionally observed multi-layering of the
colonic epithelial cells in some of the non-adenomatous areas, consistent
with studies demonstrating that in histologically normal colonic tissues
from FAP patients, E-cadherin is signiﬁcantly down-regulated [12,60].
These data indicate that heterozygous mutation of APC in mouse and
human is sufﬁcient to compromise epithelial polarity and normal tissue
architecture, a feature that may represent a key step in tumor initiation.
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3.1. Summary
The data presented here underscore the importance of APC in con-
trolling key components of the normal epithelial morphogenesis pro-
gram, including polarity and cell–cell and cell–matrix communication.
Down-regulation of APC in HC11 and MDCK epithelial cell lines
disrupted monolayer formation and caused multi-layering when the
cells were plated on permeable supports and signiﬁcantly perturbed ac-
inar/cyst formation in 3D culture conditions. The 3D dysmorphogenesis
phenotype of APC-knockdown cells, namely large, non-spherical struc-
tureswith abnormal polarity, was rescued by introduction of exogenous
human APC and its c-terminal end but not a central segment containing
the β-catenin binding and down-regulation domain. These data,combined with the observations that β-catenin transcriptional activity
was not induced by APC knockdown and overexpression of a stabilized
β-cateninmutant does not phenocopy APC depletion in these cells, sup-
port amodel inwhich the control of polarity andmorphogenesis byAPC
is independent of canonical Wnt pathway regulation. We identiﬁed an
APC-knockdown gene signature characterized by several genes in-
volved in cell–cell and cell–matrix interactions and tumor initiation. Im-
portantly, this may be a generalizable and physiological important role
for APC since kidney and intestinal tissues from Apc-mutant mice and
FAP patients showed defects in epithelial architecture.
It was striking that APC-knockdown epithelial cells did not have any
overt morphological defects or alterations in growth properties when
plated on solid substrata (e.g. glass or tissue culture plastic), but had
very dramatic phenotypes when cultured on permeable supports or in
3D ECM. A similar phenotype in epithelial morphogenesis has recently
CB
Fig. 6.Heterozygous APCmutation is associatedwith disrupted epithelial tissue architecture in vivo. A) In Apc+/+ colon, β-catenin (green) and E-cadherin (red) were analyzed by immu-
noﬂuorescence and are basolaterally localized. Their localization is more disorganized, diffuse and often basally located in ApcMin/+ tissues. Nuclear β-catenin is only observed in
microadenomas (white oval). Insets are higher magniﬁcation areas of interest. Scale bars, 20 μm. B) Immunohistochemistry for MUC1 (brown) shows that it is mislocalized and not re-
stricted to the apical membrane in kidney tissues from ApcMin/+ mice compared to Apc+/+ tissues. Tissues from ApcMin/+ are characterized by gaps between tubules and multi-layering
of epithelial cells (black arrows). Scale bars, 20 μm. C) In non-adenomatous FAP colon tissues, β-catenin (green) is basolateral located, and MUC1 (red) is apical, in some areas (top),
but other areas (middle/bottom panels) show cytosolic and basal β-catenin (black arrows) and intracellular MUC1 (white arrows). Multi-layering is evident (small white arrows). Insets
are higher magniﬁcation areas of interest. Scale bars, 20 μm.
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epithelium-associated ring chromosome 1 (DEAR1). In human mam-
mary epithelial cells, loss of DEAR1 causes no change in 2D growth;
however, these cells exhibit irregular acini morphogenesis and loss of
polarity in 3D culture [11]. These differences presumably occur because
on plastic or glass, the cells are not receiving asymmetric polarization
cues that are necessary for orienting their axis of polarity in 3D [9].
APC may be required for receiving or integrating these cues, such as
those derived from cell–matrix interactions.
3.2. Potential molecular mechanisms downstream of APC in regulating
polarity and morphogenesis
A multi-layering phenotype loss of contact inhibition has been ob-
served inMDCK cells in which a kinase-dead or constitutively activated
Rac1 effector p21-activated kinase (PAK1) was introduced [84]. Consis-
tent with these data, the expression of a constitutively active PAK1 in
MDCK cells misorients the apical surface and induces a multi-lumen
phenotype, identical to the effect of β1 integrin inhibition [14]. In fact,
Yu et al. [81] showed that β1 integrin orients epithelial polarity in the
3D MDCK model through Rac1 and laminin signaling, an effect that is
likely mediated by PAK1. In addition, APC loss has been shown to regu-
late directionality of cell extrusion [39] or apical constriction through
RhoI and Myosin II in Drosophila [86]. We have previously shown that
Apcmutation in PyMT-drivenmammary tumor cells results in hyperac-
tivation of focal adhesion kinase signaling [56,57]. Consistently, en-
hanced FAK phosphorylation and activation is also observed in
intestinal tumormodels from Apc-knockoutmice, and FAK activity is re-
quired for tumorigenesis in these animals [3]. It is possible that APC reg-
ulates the signaling pathways downstreamof cell–ECM interactions and
its loss uncouples integrin/ECM-mediated polarization andmorphogen-
esis signaling pathways. Further support for this hypothesis is provided
by the gene expression changes observed in APC-knockdown cells
grown in 3D culture conditions. EMP2 is an intriguing candidate given
its role in mediating β1 integrin signaling [21,44], previously describedas a critical component of MDCK cell polarity [53,81], and the APC/FAK
crosstalk identiﬁed in Apc-mutant tumors by our laboratory [56,57]
and others [3]. Furthermore, EMP2 and MUC16 are both early markers
of tumor development [21,25], consistent with the model of APC loss
resulting in dysregulation of epithelial polarity preceding tumorigene-
sis. The speciﬁc molecular mechanism by which APC controls these
pathways is the focus of current study but may involve interactions of
APC with actin itself or actin remodeling proteins such as the Rho
GTPase effector IQGAP [76] or the Rac and Cdc42 guanine-exchange fac-
tors Asef-1 and -2 [32–34].
Another attractive possibility is that APC elicits its control of epithe-
lial polarization and morphogenesis through its direct and indirect in-
teractions with the plus-ends of MTs, particularly during mitosis. APC
localizes to the kinetochores and centrosomes in mitotic cells, and its
mutation is associated with defects in chromosome segregation/cyto-
kinesis, and genomic instability [20,31]. Mitotic spindle orientation is
disrupted in intestinal crypts heterozygous for an Apc mutation and
even more dramatically in tumors from Apc-mutant mice that dem-
onstrate loss of heterozygosity (LOH) [19]. Recent work has shown
that APC is necessary for proper spindle orientation perpendicular
to the apical surface in the stem cell compartment of human and
mouse gastrointestinal epithelium, and that this alignment is required
for asymmetric stem cell division [59]. Studies by den Elzen et al. [15]
demonstrated that adherens junctions provide a necessary cue for
proper planar spindle orientation in MDCK monolayers, and that E-
cadherin disruption mislocalizes APC. Furthermore, APC is required
for spindle alignment during symmetric cell division in this model
[15]. The APC partner IQGAP also has been implicated in cytokinesis
[69]. Additionally, the kinesin KIF17 helps to localize APC to the
plus ends of a subset of MTs, and KIF17 depletion results in aberrant
3D epithelial cysts that lack both a central lumen and polarized apical
markers [30]. A recently characterized integrin-linked kinase (ILK)-
MT pathway to regulate the delivery of apical cargo to the correct
membrane domain [2] raises the attractive possibility that APC pro-
vides a link between integrin signaling and MTs in epithelia.
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Our observation that the c-terminus of APC is sufﬁcient to rescue the
morphogenesis defects in APC-knockdown epithelial cells was surpris-
ing given how large the full-length protein is and suggests that the in-
teraction of APC with actin or tubulin through the basic region, or EB1
via its adjacent binding region, might mediate these effects. However,
it is possible that the c-terminal PDZ-binding domain is also critical
through its association with Scrib and Dlg tumor suppressors, compo-
nents of the Lgl/Scrib/Dlg basolateral polarity and domain identity com-
plex. In fact, depletion of Scrib in MCF-10A breast epithelial cells causes
3D dysmorphogenesis with luminal ﬁlling and decreased apoptosis
[85]. Dlg is required for APC-mediated front–rear polarity in astrocytes
[18] and apical–basal polarity in mouse embryonic development and
Drosophila [38,64,73]. In addition, loss of hDlg has been shown to result
in resistance to anoikis [40], another mechanism by which loss of APC
may regulate the morphological changes observed herein. Additional
structure–function and mutagenesis studies are required to further
map the domains of APC necessary to control epithelial polarity and
morphogenesis.
3.4. Conclusion
Because APC is commonly mutated or down-regulated in epithelial
cancers, it is important to consider how loss of APC-mediated control
of morphogenesis and polarization may contribute to tumor initiation.
Our previous [58] and current work demonstrate that heterozygous
APC-mutant tissues recapitulate many of the architectural abnormali-
ties modeled by APC-knockdown in epithelial cell lines. These data are
consistentwith other studies illustrating that Apc-knockout colonicmu-
cosa and tumors have defective barrier function [29,68] and that intes-
tinal epithelial cells from histologically normal heterozygous Apc
transgenic and mutant tissues had altered migration and patterns of
gene expression along the crypt-villus axis [27,77]. While kidney tu-
mors have not been identiﬁed in the ApcMin/+ mice or FAP patients,
there is a connection between Gardner's syndrome (the non-intestinal
tumors of FAP patients) and cilia [22]. Further, homozygous deletion
of Apc in the kidney predisposes to tumorigenesis [67], suggesting
that APC plays a critical tumor suppressive role in the kidney. These
ﬁndings collectively support a model in which mutation of one APC al-
lele, or decreased APC expression by gene methylation, is sufﬁcient to
perturb epithelial polarization and architecture so as to uncouple
growth and survival cues and promote genomic instability to promote
carcinogenesis.
4. Materials and methods
4.1. Cell culture
HC11mammary epithelial cells were obtained from J. Rosen (Baylor
University, Houston, TX, USA) and cultured in RPMI (Mediatech,
Manassas, VA, USA) supplementedwith 10% FBS (Hyclone, Fisher Scien-
tiﬁc, Pittsburgh, PA, USA), 10 ng/ml EGF (Fisher Scientiﬁc) and 5 μg/ml
insulin (Sigma, St. Louis, MO, USA). MadinDarby Canine Kidney
(MDCK) cells were obtained from K. Matlin (University of Chicago, Chi-
cago, IL, USA) and were cultured in DMEM (Mediatech) with 5% FBS,
2 mM L-glutamine (Mediatech), and 10 mM HEPES (Fisher Scientiﬁc).
MDCK cells that inducibly express stabilized β-catenin were generated
by stable transfection of T23 cells (from M. Zegers at the Radboud Uni-
versity Nijmegen Medical Centre, The Netherlands; [6]) with pTRE2-
S37Aβ-catenin and maintained in growth medium supplemented with
5 μg/ml puromycin (Sigma), 6 μg/ml blasticidin (Life Technologies,
Grand Island, NY, USA), and 20 ng/ml doxycycline (DOX, Sigma). To
generate that construct, S37A β-catenin (from S. Beyers at Georgetown
University, Washington, DC, USA) was excised with BamHI (New En-
gland Biolabs, Ipswich, MA, USA) and cloned into the BamHI site ofpTRE2 (Clontech, Mountain View, CA, USA). Expression was veriﬁed
by GFP ﬂuorescence and Western blotting with a HA antibody
(Santa Cruz, Dallas, TX, USA). For monolayers, 5 × 105 cells were plated
on 6-well 0.4 μm Transwells (Fisher Scientiﬁc) and were ﬁxed for im-
munoﬂuorescence at day 5. For 3D culture, 1.25 × 104 cells were plated
on top of 50 μl growth factor-reduced Matrigel (BD Biosciences, San
Jose, CA, USA) in an 8-chamber slide in 2%Matrigel assaymedium as de-
scribed [13]. Acini were photographed or ﬁxed for IF at the indicated
times.
4.2. APC knockdown
Viral supernatant from four unique APC-speciﬁc shRNAs in the
pLKO.1 lentiviral vector (Sigma) was used to infect epithelial cells at
an MOI of 5. Negative control (pLKO.1 empty vector or SHC-002 scram-
bled shRNA) lentiviral vectors (Sigma) were expressed in HEK293FT
cells, and viral supernatant was used for infection into epithelial cells
at an MOI of 5. Infected pools were selected in 1.5 μg/ml (HC11) or
4 μg/ml (MDCK) puromycin. Knockdown was veriﬁed byWestern blot-
ting of the protein lysates as described below. For rescue studies, APC-
knockdown and control cells were stably transfected with either
empty vector, full-length hAPC, c-terminal APC fragment, or a middle
fragment of APC and selected in 2.0 mg/ml (HC11) or 0.6 mg/ml
(MDCK) G418. The construct encoding the middle fragment of APC
(bp 678–6513) was generated by EcoRI digestion of pBS(SK)APC [23]
and subcloning into the EcoRI site of pEGFP-C3 (Clontech), and the
c-terminal fragment (bp 6513–8500) was cloned by EcoRI/BamHI di-
gestion of pEGFP APC [26] and subcloning into EcoRI/BamHI-digested
pEGFP-C3. Expression was veriﬁed by transient transfection of the
constructs and GFP ﬂuorescence.
4.3. Immunoﬂuorescence
Cells on Transwells were ﬁxed with 4% paraformaldehyde (PFA,
Fisher), quenched with 50 mM NH4Cl, and permeabilized with 0.1%
Triton X-100 prior to blocking in 0.2% ﬁsh skin gelatin. Stainingwas per-
formed with the following primary antibodies diluted in 0.1% goat
serum (except for Scrib, which was diluted in 0.1% donkey serum):
anti-APC rabbit polyclonal (1:200; a gift from Inke Näthke, University
of Dundee, Dundee, Scotland [49]); anti-β-catenin monoclonal (1:200;
BD Biosciences); anti-E-cadherin monoclonal (1:200; BD Biosciences);
anti-MUC1 monoclonal (1:100; Abcam, Cambridge, MA, USA), anti-Dlg
monoclonal (1:100; BD Biosciences), anti-Scribble goat polyclonal
(1:100; Santa Cruz). Expression was detected using Alexa-conjugated
secondary antibodies (1:1000 each; Life Technologies). For visualization
of F-actin, cells were co-stained with Alexa-conjugated phalloidin
(1:200; Life Technologies). All slides were mounted with Fluoromount
G with Hoechst dye. Cells in 2D were ﬁxed with 3.7% formaldehyde,
permeabilized with 0.3% Triton X-100, and incubated with the primary
antibody anti-green ﬂuorescence protein (GFP; 1:400; Life Technolo-
gies) for 1 h. Expression was detected using Alexa-ﬂuor conjugated
secondary antibodies (1:1000; Life Technologies) and cells were coun-
terstained with Hoescht dye and mounted with Fluoromount G. For
3D cultures, cells were ﬁxed in 4% PFA at the indicated time points
and permeabilized with 0.5% Triton X-100. Blocking was performed
for 1 h with 0.1% goat serum, followed by overnight staining with the
following primary antibodies diluted in blocking buffer: anti-β-catenin
(1:200; BD Biosciences); anti-E-cadherin (1:200; BD Biosciences);
anti-gp135 culture supernatant (1:2; provided by K. Matlin at the Uni-
versity of Chicago and originally from G. Ojakian, SUNY Downstate,
Brooklyn, NY, USA; [52]). Expression was detected using Alexa-ﬂuor
conjugated secondary antibodies (1:1000; Life Technologies). To de-
marcate the actin cytoskeleton, cysts were stained with Alexa-
conjugated phalloidin (1:200; Life Technologies) and counterstained
with Hoescht. For tissues, slides were deparafﬁnized, hydrated, and
blocked for 1 h with 2% BSA and 0.2% NFDM. Tissues were stained for
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anti-β-catenin (1:100; BD Biosciences); anti-E-cadherin (1:100; BD
Biosciences); and anti-MUC1 (1:100; Abcam). Expression was detected
using Alexa-conjugated secondary antibodies (1:1000 in blocking
buffer; Life Technologies). All slides were mounted with Fluoromount
G with Hoescht dye.
4.4. Western blotting
Total cell lysates were extracted with 50 mM Tris pH 7.5, 0.1% IGEP
AL, 100 mM NaCl, 1 mM MgCl2, 5 mM EDTA and protease inhibitors
and sonicated. 50 μg of lysates from each cell line was separated on a
7% SDS-PAGE gel and transferred to Immobilon P membrane. Blots
were probed with 1:3000 anti-APC polyclonal antibody [75] obtained
from K. Neufeld (University of Kansas, Lawrence, KS, USA) and 1:1000
anti-actin monoclonal antibody (Sigma) in blocking buffer (5% nonfat
dried milk in TBST). HCT116 and SW480 lysates were used as a control
for full-length and mutant APC, respectively. Densitometry was per-
formed using ImageJ software (NIH).
4.5. TCF reporter assay
Cells were plated in a 24-well plate at a density of 1 × 104 cells/well
and transfected using Optifect (Life Technologies) with 2.6 μg of
pTOPﬂash or pFOPﬂash (obtained from H. Clevers at the Hubrecht Insti-
tute, The Netherlands) along with pRL-TK (Promega) for determination
of transfection efﬁciency. Lysates were harvested after 48 h and ana-
lyzed using the Dual Luciferase Assay System kit (Promega, Madison,
WI, USA). Luciferase activity was normalized for transfection efﬁciency
and graphed as ratio of TOPﬂash/FOPﬂash activity. The SW480 human
colon cancer cell line was used as a positive control. Cells were treated
with 30 mM LiCl as a positive control for Wnt activation in MDCK cells.
4.6. Morphological analyses
Acini/cysts were visualized under phase-contrast microscopy using
an inverted Zeiss Axioscope microscope and images captured with
Axiovision software. For quantiﬁcation, 10 ﬁelds with at least 50 struc-
tures were counted per cell line, and the percentage of each category
was plotted. Statistical analyses were performed using Fisher's exact
test. ImageJ software (NIH) was used for analysis of cyst size, and a
one-way ANOVA determined signiﬁcance.
4.7. Microarray and gene expression analysis of 3D cultures
RNAwas isolated from3D cultures ofMDCK cells (at day 5) and sub-
jected to microarray analysis using the Functional Genomics Core facil-
ity at the University of Chicago and three biological replicates. RNA
quality was conﬁrmed using the Agilent Bioanalyzer 2100 prior to hy-
bridization to Affymetrix Canine Genome 2.0 arrays. Data analysis was
performed using dChip software (Harvard), and the threshold for
selecting signiﬁcant genes was set for a relative difference of N1.2-fold
with p b 0.05. For validation of altered gene expression, cDNA was syn-
thesized using iScript Reverse Transcriptase (Bio-Rad, Hercules, CA,
USA), and real-time PCR was performed with Advanced Sybr GreenTable 1
Primers used for gene expression analysis of APC-knockdown MDCK cells.
Gene Forward primer (5′–3′) Reverse primer (5′–3′)
CXCR7 TTG CTA CCT GCA TGG GAT ATG AGA GGT TCC GCT TCG TTT C
ADAMTS6 CAC TGG TAG TGG CAG ACA AA CTA GGC TGG AAT CAC GGT AAA G
LCN2 GAG CCA TGA GAC CCT TCT TAC CCA GGT GGC ATG TGT TTA TTT AG
COL4A1 CAG AGA TGG TCT GGA AGG ATT G GTC GGG CGT CGA AGT AAA T
MUC16 CTT CTG GGC CAT CAT CCT TAT C CCT CGT ATT CTC CCT CCT TCT
EMP2 TGG TGG GTA GGA GAA GAG TT GCC TGC ATC GTG GAG TAA T(Life Technologies). Primer sequences used are listed in Table 1. Gene
expression changes were quantiﬁed using the ΔΔC(t) method.
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